Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Myomo (MYO) EPS (Weighted Average and Diluted) (2021 - 2025)

Myomo filings provide 5 years of EPS (Weighted Average and Diluted) readings, the most recent being -$0.09 for Q3 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 200.0% to -$0.09 in Q3 2025 year-over-year; TTM through Sep 2025 was -$0.28, a 21.74% decrease, with the full-year FY2024 number at -$0.16, up 42.86% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.09 in Q3 2025 for Myomo, up from -$0.11 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.17 in Q4 2024 to a low of -$0.51 in Q4 2021.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.11 (2023), compared with a mean of -$0.19.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 348.37% in 2024 and later crashed 266.67% in 2025.
  • Myomo's EPS (Weighted Average and Diluted) stood at -$0.51 in 2021, then surged by 45.1% to -$0.28 in 2022, then surged by 75.0% to -$0.07 in 2023, then skyrocketed by 348.37% to $0.17 in 2024, then crashed by 151.77% to -$0.09 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.09 (Q3 2025), -$0.11 (Q2 2025), and -$0.08 (Q1 2025) per Business Quant data.